Redmile Group as of March 31, 2021
Portfolio Holdings for Redmile Group
Redmile Group holds 86 positions in its portfolio as reported in the March 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Fate Therapeutics (FATE) | 15.0 | $1.1B | 13M | 82.45 | |
| Allakos (ALLK) | 3.9 | $278M | 2.4M | 114.78 | |
| Igm Biosciences (IGMS) | 3.7 | $263M | 3.4M | 76.69 | |
| Argenx Se Sponsored Adr (ARGX) | 3.3 | $234M | 850k | 275.39 | |
| Amicus Therapeutics (FOLD) | 2.9 | $209M | 21M | 9.88 | |
| Beam Therapeutics (BEAM) | 2.9 | $203M | 2.5M | 80.04 | |
| Deciphera Pharmaceuticals (DCPH) | 2.7 | $195M | 4.4M | 44.84 | |
| Invitae (NVTAQ) | 2.6 | $185M | 4.9M | 38.21 | |
| Adc Therapeutics Sa SHS (ADCT) | 2.5 | $178M | 7.3M | 24.41 | |
| Shattuck Labs (STTK) | 2.3 | $164M | 5.6M | 29.24 | |
| Medavail Holdings Ord | 2.3 | $164M | 12M | 14.00 | |
| Oak Street Health | 2.2 | $159M | 2.9M | 54.27 | |
| Krystal Biotech (KRYS) | 2.2 | $159M | 2.1M | 77.04 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 1.9 | $136M | 829k | 164.37 | |
| Seagen | 1.8 | $130M | 937k | 138.86 | |
| Pliant Therapeutics (PLRX) | 1.8 | $126M | 3.2M | 39.33 | |
| Replimune Group (REPL) | 1.8 | $126M | 4.1M | 30.51 | |
| Medtronic SHS (MDT) | 1.6 | $116M | 979k | 118.13 | |
| Scholar Rock Hldg Corp (SRRK) | 1.6 | $110M | 2.2M | 50.66 | |
| Nurix Therapeutics (NRIX) | 1.5 | $103M | 3.3M | 31.09 | |
| Kymera Therapeutics (KYMR) | 1.4 | $101M | 2.6M | 38.86 | |
| Atara Biotherapeutics (ATRA) | 1.4 | $99M | 6.9M | 14.36 | |
| Stoke Therapeutics (STOK) | 1.4 | $99M | 2.5M | 38.84 | |
| Zentalis Pharmaceuticals (ZNTL) | 1.4 | $96M | 2.2M | 43.39 | |
| Annexon (ANNX) | 1.4 | $96M | 3.5M | 27.84 | |
| GenMark Diagnostics | 1.2 | $86M | 3.6M | 23.90 | |
| Livanova SHS (LIVN) | 1.2 | $83M | 1.1M | 73.73 | |
| Repare Therapeutics Ord (RPTX) | 1.2 | $82M | 2.7M | 30.69 | |
| Ngm Biopharmaceuticals (NGM) | 1.1 | $80M | 2.8M | 29.07 | |
| Dex (DXCM) | 1.1 | $80M | 223k | 359.39 | |
| Regenxbio Inc equity us cm (RGNX) | 1.1 | $80M | 2.3M | 34.11 | |
| Tcr2 Therapeutics Inc cs | 1.1 | $80M | 3.6M | 22.08 | |
| ImmunoGen | 1.1 | $79M | 9.7M | 8.10 | |
| Epizyme | 1.1 | $77M | 8.8M | 8.71 | |
| Akero Therapeutics (AKRO) | 1.0 | $73M | 2.5M | 29.01 | |
| Alx Oncology Hldgs (ALXO) | 1.0 | $72M | 979k | 73.74 | |
| Nevro (NVRO) | 1.0 | $72M | 517k | 139.50 | |
| Atea Pharmaceuticals (AVIR) | 1.0 | $72M | 1.2M | 61.75 | |
| Celldex Therapeutics Com New (CLDX) | 1.0 | $70M | 3.4M | 20.60 | |
| Cigna Corp (CI) | 1.0 | $68M | 280k | 241.74 | |
| Selectquote Ord (SLQT) | 0.8 | $59M | 2.0M | 29.51 | |
| Neoleukin Therapeutics | 0.7 | $51M | 4.1M | 12.31 | |
| Charles River Laboratories (CRL) | 0.7 | $48M | 167k | 289.83 | |
| Nuvation Bio Com Cl A (NUVB) | 0.7 | $48M | 4.5M | 10.45 | |
| Anthem (ELV) | 0.7 | $47M | 130k | 358.95 | |
| Prothena Corp SHS (PRTA) | 0.7 | $47M | 1.9M | 25.12 | |
| ICU Medical, Incorporated (ICUI) | 0.6 | $46M | 224k | 205.44 | |
| Biogen Idec (BIIB) | 0.6 | $46M | 163k | 279.75 | |
| Allovir (ALVR) | 0.6 | $46M | 1.9M | 23.40 | |
| Genmab A/s Sponsored Ads (GMAB) | 0.6 | $44M | 1.3M | 32.83 | |
| Lava Therapeutics Nv SHS (LVTX) | 0.6 | $43M | 2.8M | 15.19 | |
| UnitedHealth (UNH) | 0.6 | $43M | 114k | 372.07 | |
| Atreca Cl A Com (BCEL) | 0.5 | $38M | 2.5M | 15.33 | |
| Amedisys (AMED) | 0.5 | $35M | 133k | 264.79 | |
| Achilles Therapeutics Sponsored Ads (ACHL) | 0.5 | $35M | 2.1M | 16.55 | |
| Avita Therapeutics (RCEL) | 0.5 | $33M | 1.7M | 19.82 | |
| Catalent (CTLT) | 0.5 | $33M | 312k | 105.31 | |
| Zymeworks | 0.4 | $31M | 986k | 31.58 | |
| Ppd | 0.4 | $31M | 821k | 37.84 | |
| Hookipa Pharma Inc equity (HOOK) | 0.3 | $25M | 1.8M | 13.45 | |
| Immatics SHS (IMTX) | 0.3 | $23M | 2.1M | 11.21 | |
| Ardelyx (ARDX) | 0.3 | $23M | 3.5M | 6.62 | |
| Gritstone Oncology Ord (GRTS) | 0.3 | $23M | 2.4M | 9.43 | |
| Bioventus Com Cl A (BVS) | 0.3 | $23M | 1.5M | 15.28 | |
| Itamar Med Sponsored Ads | 0.3 | $22M | 919k | 23.95 | |
| 1life Healthcare | 0.3 | $22M | 562k | 39.08 | |
| Innovage Hldg Corp (INNV) | 0.3 | $22M | 850k | 25.79 | |
| Stereotaxis Com New (STXS) | 0.3 | $22M | 3.2M | 6.72 | |
| Vesper Healthcare Acqstn Cor Com Cl A | 0.3 | $21M | 2.0M | 10.80 | |
| Cytosorbents Corp Com New (CTSO) | 0.3 | $19M | 2.1M | 8.68 | |
| Quanterix Ord (QTRX) | 0.2 | $18M | 300k | 58.47 | |
| Profound Med Corp Com New (PROF) | 0.2 | $17M | 846k | 20.14 | |
| Yumanity Therapeutics | 0.2 | $11M | 611k | 18.10 | |
| Uniqure Nv SHS (QURE) | 0.1 | $9.6M | 284k | 33.69 | |
| Dynavax Technologies Corp Com New (DVAX) | 0.1 | $8.7M | 883k | 9.83 | |
| Cabaletta Bio (CABA) | 0.1 | $7.7M | 696k | 11.10 | |
| Xeris Pharmaceuticals | 0.1 | $7.7M | 1.7M | 4.51 | |
| Ayala Pharmaceuticals Incorporated | 0.1 | $7.3M | 668k | 10.91 | |
| Neuronetics (STIM) | 0.1 | $6.2M | 500k | 12.37 | |
| Talis Biomedical Corp | 0.1 | $5.1M | 400k | 12.85 | |
| Aprea Therapeutics | 0.0 | $3.5M | 695k | 5.10 | |
| Syros Pharmaceuticals | 0.0 | $1.6M | 212k | 7.48 | |
| Ovid Therapeutics (OVID) | 0.0 | $490k | 122k | 4.02 | |
| Wave Life Sciences SHS (WVE) | 0.0 | $443k | 79k | 5.61 | |
| Tricida | 0.0 | $290k | 55k | 5.30 | |
| Castlight Health CL B | 0.0 | $15k | 10k | 1.47 |
